AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 124 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $83,000 | -37.6% | 10,333 | -11.2% | 0.02% | -25.9% |
| Q4 2019 | $133,000 | +20.9% | 11,633 | -1.0% | 0.03% | +12.5% |
| Q3 2019 | $110,000 | +1.9% | 11,748 | -4.7% | 0.02% | -4.0% |
| Q2 2019 | $108,000 | -42.6% | 12,328 | +46.9% | 0.02% | -51.0% |
| Q3 2018 | $188,000 | – | 8,392 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 740,585 | $17,330,000 | 8.11% |
| Palo Alto Investors LP | 2,906,194 | $68,005,000 | 5.28% |
| Opaleye Management Inc. | 220,000 | $5,148,000 | 3.21% |
| Endurant Capital Management LP | 265,180 | $6,205,000 | 2.01% |
| FALCON POINT CAPITAL, LLC | 381,081 | $8,917,000 | 1.54% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 1,470,000 | $34,398,000 | 1.06% |
| AlphaOne Investment Services, LLC | 91,824 | $2,149,000 | 0.88% |
| ASHFORD CAPITAL MANAGEMENT INC | 153,325 | $3,588,000 | 0.85% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 55,097 | $1,289,000 | 0.84% |
| Camber Capital Management LP | 600,000 | $14,040,000 | 0.82% |